前收市價 | 1.4800 |
開市 | 1.4800 |
買盤 | 0.0000 |
賣出價 | 0.0000 |
拍板 | 90.00 |
到期日 | 2025-06-20 |
今日波幅 | 1.4800 - 1.4800 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 339 |
MRK earnings call for the period ending March 31, 2024.
On Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8 billion, up 9% year-over-year, beating the consensus estimate of $15.2 billion. Excluding the impact of foreign exchange, sales increased 24%. Merck reported adjusted EPS of $2.07, up 48%Y/Y, beating the consensus of $1.88. Merck’s pharmaceutical unit booked $14.01 billion in revenue during the first quarter, up 10% Y/Y. Related: Merck’s $11B Bet Pays As FDA Approves Sotatercept For Rare Lung Disease. Me
Merck (MRK) beats first-quarter estimates for earnings and sales. The company raises its EPS range for 2024. Stock rises in pre-market.